These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24331184)

  • 21. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.
    Bowker SL; Majumdar SR; Veugelers P; Johnson JA
    Diabetes Care; 2006 Feb; 29(2):254-8. PubMed ID: 16443869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer risk.
    Brodovicz KG; Kou TD; Alexander CM; O'Neill EA; Engel SS; Girman CJ; Goldstein BJ
    Diabetes Obes Metab; 2012 Dec; 14(12):1123-8. PubMed ID: 22831166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is insulin-dependent diabetes and obesity a predisposition for endometrial and pancreatic carcinoma?
    Gojnic M; Dugalic V; Brankovic M; Stojanovic I; Acimovic M; Vasiljevic B
    Clin Exp Obstet Gynecol; 2010; 37(2):152-4. PubMed ID: 21077512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are sulfonylurea and insulin therapies associated with a larger risk of cancer than metformin therapy? A retrospective database analysis.
    Kowall B; Rathmann W; Kostev K
    Diabetes Care; 2015 Jan; 38(1):59-65. PubMed ID: 25336750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin use in an obese diabetic patient from weeks 1 to 21 of pregnancy.
    Nagai T; Imamura M; Mori M
    J Med; 2003; 34(1-6):163-8. PubMed ID: 17682321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.
    Eibl G; Cruz-Monserrate Z; Korc M; Petrov MS; Goodarzi MO; Fisher WE; Habtezion A; Lugea A; Pandol SJ; Hart PA; Andersen DK;
    J Acad Nutr Diet; 2018 Apr; 118(4):555-567. PubMed ID: 28919082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity and cancer pathogenesis.
    Berger NA
    Ann N Y Acad Sci; 2014 Apr; 1311():57-76. PubMed ID: 24725147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-Varying Risk for Breast Cancer Following Initiation of Glucose-Lowering Therapy in Women with Type 2 Diabetes: Exploring Detection Bias.
    Bowker SL; Lin M; Eurich DT; Johnson JA
    Can J Diabetes; 2017 Apr; 41(2):204-210. PubMed ID: 27908558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
    Avilés-Santa L; Sinding J; Raskin P
    Ann Intern Med; 1999 Aug; 131(3):182-8. PubMed ID: 10428734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes mellitus and the risk of cancer.
    Pandey A; Forte V; Abdallah M; Alickaj A; Mahmud S; Asad S; McFarlane SI
    Minerva Endocrinol; 2011 Sep; 36(3):187-209. PubMed ID: 22019750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes mellitus: Complex interplay between metformin, AKI and lactic acidosis.
    Rhee CM; Kalantar-Zadeh K
    Nat Rev Nephrol; 2017 Sep; 13(9):521-522. PubMed ID: 28736433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin and Pancreatic Cancer Risk in Patients With Type 2 Diabetes.
    Tseng CH
    Pancreas; 2018 Oct; 47(9):e57-e59. PubMed ID: 30199488
    [No Abstract]   [Full Text] [Related]  

  • 33. Comment on: association of B12 deficiency and clinical neuropathy with metformin use in type 2 diabetes patients.
    Chowta MN; Tiwary G
    J Postgrad Med; 2014; 60(1):96-7. PubMed ID: 24625957
    [No Abstract]   [Full Text] [Related]  

  • 34. Comment: association of B12 deficiency and clinical neuropathy with metformin use in type 2 diabetes patients.
    Shah VN
    J Postgrad Med; 2014; 60(1):95. PubMed ID: 24625956
    [No Abstract]   [Full Text] [Related]  

  • 35. Diabetes medications and cancer: a way out of uncertainty.
    Gallo M; Esposito K; Giugliano D
    Diabetes Res Clin Pract; 2012 Aug; 97(2):175-7. PubMed ID: 22560795
    [No Abstract]   [Full Text] [Related]  

  • 36. Toxicity of Metformin and Hypoglycemic Therapies.
    Akhter MS; Uppal P
    Adv Chronic Kidney Dis; 2020 Jan; 27(1):18-30. PubMed ID: 32146997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo-controlled 4.3-year trial.
    Out M; Miedema I; Jager-Wittenaar H; van der Schans C; Krijnen W; Lehert P; Stehouwer C; Kooy A
    Diabetes Obes Metab; 2018 Jan; 20(1):219-223. PubMed ID: 28681986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin-associated lactic acidosis in a patient with vertebral artery dissection.
    Packer CD
    South Med J; 2006 Oct; 99(10):1147-8. PubMed ID: 17100045
    [No Abstract]   [Full Text] [Related]  

  • 39. [Insulin based combination treatments of patients with obesity and type 2 diabetes].
    Schütt M
    Internist (Berl); 2011 Jan; 52(1):43-52; quiz 53. PubMed ID: 21161640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer protection.
    Harv Health Lett; 2005 Oct; 30(12):7. PubMed ID: 16278981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.